DICP OpenIR
Antifungal activity of a novel compound from Burkholderia cepacia against plant pathogenic fungi
Li, X.; Quan, C.-S.; Fan, S.-D.
关键词Antifungal Activity Burkholderia Cepacia Cf66i Morphological Alteration Plant Pathogenic Fungi
刊名LETTERS IN APPLIED MICROBIOLOGY
2007-11-01
DOI10.1111/j.1472-765X.2007.02221.x
45期:5页:508-514
收录类别SCI
文章类型Article
WOS标题词Science & Technology ; Life Sciences & Biomedicine
类目[WOS]Biotechnology & Applied Microbiology ; Microbiology
研究领域[WOS]Biotechnology & Applied Microbiology ; Microbiology
关键词[WOS]APHANOMYCES ROOT-ROT ; PYTHIUM DAMPING-OFF ; PSEUDOMONAS-CEPACIA ; BIOLOGICAL-CONTROL ; PYRROLNITRIN ; INHIBITION ; BIOCONTROL ; SOLANI
英文摘要Aims: To investigate antifungal activity of a novel compound (named as CF66I provisionally) against plant pathogenic fungi, mainly including Fusarium sp., Colletotrichum lindemuthianum, Rhizoctonia solani, etc.
语种英语
WOS记录号WOS:000250362700009
引用统计
被引频次:19[WOS]   [WOS记录]     [WOS相关记录]
文献类型期刊论文
条目标识符http://cas-ir.dicp.ac.cn/handle/321008/140608
专题中国科学院大连化学物理研究所
作者单位1.Dalian Natl Univ, Life Sci Coll, Dalian 116600, Peoples R China
2.Chinese Acad Sci, Dalian Inst Chem Phys, Dalian, Peoples R China
3.Chinese Acad Sci, Grad Univ, Beijing, Peoples R China
推荐引用方式
GB/T 7714
Li, X.,Quan, C.-S.,Fan, S.-D.. Antifungal activity of a novel compound from Burkholderia cepacia against plant pathogenic fungi[J]. LETTERS IN APPLIED MICROBIOLOGY,2007,45(5):508-514.
APA Li, X.,Quan, C.-S.,&Fan, S.-D..(2007).Antifungal activity of a novel compound from Burkholderia cepacia against plant pathogenic fungi.LETTERS IN APPLIED MICROBIOLOGY,45(5),508-514.
MLA Li, X.,et al."Antifungal activity of a novel compound from Burkholderia cepacia against plant pathogenic fungi".LETTERS IN APPLIED MICROBIOLOGY 45.5(2007):508-514.
条目包含的文件
条目无相关文件。
个性服务
推荐该条目
保存到收藏夹
查看访问统计
导出为Endnote文件
谷歌学术
谷歌学术中相似的文章
[Li, X.]的文章
[Quan, C.-S.]的文章
[Fan, S.-D.]的文章
百度学术
百度学术中相似的文章
[Li, X.]的文章
[Quan, C.-S.]的文章
[Fan, S.-D.]的文章
必应学术
必应学术中相似的文章
[Li, X.]的文章
[Quan, C.-S.]的文章
[Fan, S.-D.]的文章
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。